Interstitial lung disease

Related records

Broader conditions (6)

• Disease
• Disease by body system or component
• Human disease
• Lower respiratory tract disorder
• Lung disorder
• Respiratory system disorder

Narrower conditions (97)

• Adult pulmonary Langerhans cell histiocytosis
• Alveolar capillary dysplasia with misalignment of pulmonary veins
• Anthracosilicosis
• Anthracosis
• Asbestosis
• Bagassosis
• Baritosis
• Bird fancier's lung
• Bronchiolitis obliterans syndrome
• Bronchiolocentric pattern of interstitial pneumonia
• Byssinosis
• Caplan syndrome
• Cellular interstitial pneumonitis
• Chronic beryllium disease
• Chronic pneumonitis of infancy
• Congenital chylothorax
• Congenital emphysematous lung disease due to Filamin A loss-of-function variant
• Cork-handlers' disease
• Diffuse pulmonary fibrosis
• Drug or radiation exposure-related interstitial lung disease

Trials (428)

• "Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps.
• 129Xe MRI Cardiopulmonary
• A Clinical Trial for CTD-ILD Treatment
• A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up
• A Home-based Physical Activity Programme for Patients With Advanced Interstitial Lung Diseases (iLiFE)
• A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
• A Non-pharmacological Cough Control Therapy
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
• A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
• A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
• A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
• A Study of Mosliciguat in PH-ILD
• A Study of the Natural Progression of Interstitial Lung Disease (ILD)
• A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease
• A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
• A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome
• A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
• A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
• A Study to Evaluate the Diagnostic Performance of Portable Oscillometry Across Chronic Respiratory Diseases
• A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Approved drugs (1)

• Nintedanib esylate

Drugs in development (24)

• Abituzumab Phase 2
• AD-214 Phase 1
• Admilparant Phase 1
• Amitriptyline Phase 2
• Azathioprine Phase 2
• Belimumab Phase 3
• Duloxetine Phase 2
• Fentanyl citrate Phase 3
• Gadoterate meglumine Phase 2
• Hydroxychloroquine Early phase 1
• Hydroxychloroquine sulfate Phase 2
• Mycophenolate mofetil Phase 3
• Nerandomilast Phase 3
• Nintedanib Phase 3
• Pirfenidone Phase 2
• Pomalidomide Phase 2
• Rituximab Phase 3
• Sodium chloride Phase 2
• Tadalafil Phase 3
• Transcrocetinate sodium Phase 2

Other linked drugs (5)

• Betamethasone
• Dexamethasone
• Ipratropium bromide
• Prednisolone
• Xenon